Emmes - About the company
Emmes is an acquired company based in India, founded in 1977. It operates as a Provider of outsourced CRO services. Emmes has raised an undisclosed amount in funding from Behrman Capital. The company has 341 active competitors, including 14 funded and 114 that have exited. Its top competitors include companies like Parexel, Celgene and Veristat.
Company Details
- Website
- emmes.com
- Registered Address
- Rockville,Maryland
Key Metrics
Founded Year
1977
Location
Stage
Acquired
Latest Funding Round
Investors
Ranked
12th among 341 active competitors
Employee Count
1,189 as on Jun 30, 2026
Exit Details
Acquired by New Mountain Capital (Jun 21, 2022)
Legal entities associated with Emmes
Emmes is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
THE EMMES CORPORATION CIN: 541058268 , United States, Active | Dec 31, 1999 | - | 824 (As on Dec 31, 2024) | - |
EMMES SERVICES PRIVATE LIMITED CIN: U72200KA2006FTC039089 , India, Active | Apr 24, 2006 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | 195 (As on Sep 30, 2024) | |
EMMES & COMPANY LLC CIN: 5437603 , United States, Active | Nov 05, 2018 | - | - | - |
Emmes's acquisition details
Emmes got acquired by New Mountain Capital on Jun 21, 2022.
Click here to take a look at Emmes's acquisition in detail
Sign up to download Emmes' company profile
Emmes's funding and investors
Emmes has raised funding over 3 rounds. Its first funding round was on Jul 16, 2008. Its latest funding round was a PE round on Mar 04, 2019 for $*****. 1 investor participated in its latest round. Emmes has 3 institutional investors.
Here is the list of recent funding rounds of Emmes:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 04, 2019 | 8196933 | PE | 7466807 | 7724952 | 7505628 | 3516859 |
Jul 21, 2014 | 3538443 | Grant (prize money) | 9960358 | 6124032 | 5732399 | |
Jul 16, 2008 | 9691434 | Grant (prize money) | 1213584 | 7911982 | 6146941 |
View details of Emmes's funding rounds and investors
Emmes' founders and board of directors
Founder? Claim ProfileEmmes' employee count trend
Emmes has 1,189 employees as of Jun 26. Here is Emmes's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Emmes's Competitors and alternates
Top competitors of Emmes include Parexel, Celgene and Veristat. Here is the list of Top 10 competitors of Emmes, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Parexel 1983, Waltham (United States), Acquired | Global full-service CRO | - | 61/100 | |
2nd | Celgene 1986, Summit (United States), Acquired | Developer of therapies for treating cancer and inflammatory diseases | $45M | 61/100 | |
3rd | Veristat 1994, Southborough (United States), Acquired | Clinical research organization accelerating complex therapies through strategic planning and execution | - | 60/100 | |
4th | Siro Clinpharm 2000, Thane (India), Acquired | Company offering clinical development services | $5.25M | 60/100 | |
5th | A global mid-service CRO providing clinical research services | - | 59/100 | ||
6th | Syneos Health 1984, Raleigh (United States), Public | Provider of CRO clinical development | - | 58/100 | |
7th | Premier Research 1989, Durham (United States), Public | Provider of clinical trial CRO services | - | 55/100 | |
8th | Biorasi 2002, Miami (United States), Acquired | CRO delivering reliable, flexible, transparent clinical trials with scientific excellence | - | - | 54/100 |
9th | ClinChoice 1995, Fort Washington (United States), Series E | CRO focused on data management, regulatory affairs and consulting services | $212M | 53/100 | |
10th | Worldwide Clinical Trials 1986, Beverly Hills (United States), Acquired | Global CRO providing personalized support for clinical trials across diverse therapeutic areas | - | 52/100 | |
12th | Provider of outsourced CRO services | - | 49/100 |
Looking for more details on Emmes's competitors? Click here to see the top ones
Emmes's Investments and acquisitions
Emmes has not made any investments yet. Emmes has made 7 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 05, 2023 | Acquisition | 2012 | Panama (Panama) | |
Mar 21, 2023 | Acquisition | 2009 | Rockville (United States) | |
Sep 28, 2022 | Acquisition | 2004 | Milwaukee (United States) |
See all acquisitions by Emmes
Reports related to Emmes
Here is the latest report on Emmes's geography:
News related to Emmes
•
•
•
ILiAD Selects Emmes Group to Conduct Phase III Studies of Pertussis Vaccine CandidateContract Pharma•Jun 25, 2024•ILiAD Biotechnologies, Emmes
•
•
•
•
Emmes Introduces Telehealth Capabilities into Advantage eClinicalEuropean Pharmaceutical Manufacturer•Sep 28, 2023•Emmes
•
Emmes Appoints Peter Ronco as Chief Executive OfficerBusiness Wire•Sep 20, 2023•Emmes, Johnson & Johnson
•
•
Aterian Investment Partners Announces Salvatore Guccione Has Joined Board of Allentown as vice Chairmaninvestidollar.com•Jan 24, 2023•Aterian Partners, Allentown, Emmes
Are you a Founder ?
FAQs about Emmes
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company